These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19214026)

  • 1. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.
    Tigen K; Karaahmet T; Cevik C; Gurel E; Mutlu B; Basaran Y
    Am J Med Sci; 2009 Feb; 337(2):109-15. PubMed ID: 19214026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of clinical, electrocardiographic, echocardiographic and neurohumoral parameters in non-ischaemic dilated cardiomyopathy.
    Tigen K; Karaahmet T; Tanalp AC; Gurel E; Cevik C; Mutlu B; Basaran Y
    Acta Cardiol; 2008 Apr; 63(2):207-12. PubMed ID: 18468202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm.
    Tigen K; Karaahmet T; Kahveci G; Tanalp AC; Bitigen A; Fotbolcu H; Bayrak F; Mutlu B; Basaran Y
    Heart Lung Circ; 2007 Aug; 16(4):290-4. PubMed ID: 17403613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
    Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
    J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic utility of right ventricular systolic functions assessed by tissue doppler imaging in dilated cardiomyopathy and its correlation with plasma NT-pro-BNP levels.
    Tigen K; Karaahmet T; Cevik C; Gurel E; Pala S; Mutlu B; Basaran Y
    Congest Heart Fail; 2009; 15(5):234-9. PubMed ID: 19751425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
    Dini FL; Fontanive P; Conti U; Andreini D; Cabani E; De Tommasi SM
    Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of serial serum N-terminal prohormone brain natriuretic peptide levels in the prediction of outcome in children with dilated cardiomyopathy.
    Kim G; Lee OJ; Kang IS; Song J; Huh J
    Am J Cardiol; 2013 Nov; 112(9):1455-60. PubMed ID: 24035042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric Acid as prognostic marker in advanced nonischemic dilated cardiomyopathy: comparison with N-terminal pro B-type natriuretic peptide level.
    Kim H; Shin HW; Son J; Yoon HJ; Park HS; Cho YK; Han CD; Nam CW; Hur SH; Kim YN; Kim KB
    Congest Heart Fail; 2010; 16(4):153-8. PubMed ID: 20662867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of Serial N-terminal Pro-B-type Natriuretic Peptide Measurements to Predict Cardiac Death in Acute and Chronic Dilated Cardiomyopathy in Children.
    den Boer SL; Rizopoulos D; du Marchie Sarvaas GJ; Backx AP; Ten Harkel AD; van Iperen GG; Rammeloo LA; Tanke RB; Boersma E; Helbing WA; Dalinghaus M
    Am J Cardiol; 2016 Dec; 118(11):1723-1729. PubMed ID: 27692597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive value of admission amino-terminal pro-B-type natriuretic peptide on in-hospital mortality in patients with decompensated heart failure].
    Wei BQ; Yang YJ; Zhang J; Dou KF; Zhang YH; Huang XH; Kang LM; Zhang CL; Gu Q; Gao X; Yang YM; Dai Y; Yu LT; Zhang HM; Lü R
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):481-5. PubMed ID: 19927625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
    Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R
    J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
    Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
    Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure].
    Wang F; Li W; Huang J; Wang L; Bian WY; Pang HM; Wang Y; Xu ZM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Old markers, new approach to assessment of risk in heart failure.
    Kodziszewska K; Leszek P; Korewicki J; Piotrowski W
    Kardiol Pol; 2015; 73(6):387-95. PubMed ID: 25563469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle.
    Barbosa MM; Nunes Mdo C; Ribeiro AL; Barral MM; Rocha MO
    Eur J Echocardiogr; 2007 Jun; 8(3):204-12. PubMed ID: 16651029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurohormonal and echocardiographic results after CorCap and mitral annuloplasty for dilated cardiomyopathy.
    Rubino AS; Onorati F; Santarpino G; Pasceri E; Santarpia G; Cristodoro L; Serraino GF; Renzulli A
    Ann Thorac Surg; 2009 Sep; 88(3):719-25. PubMed ID: 19699885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.